O2- and pneumonia-induced lung injury. II. Properties of pulmonary surfactant.
Pulmonary surfactant was isolated from the lavage fluids of animals during the course of exposure to 100% O2, 80% O2, 40% O2, or 80% O2 plus 10(8) Pseudomonas aeruginosa instilled intratracheally and analyzed for its phospholipid composition. After 4-5 days of exposure to 100% O2, disaturated phophatidylcholine (DSPC) decreased to 87% of control, whereas the ratio of phosphatidylglycerol to phosphatidylinositol (PG/PI) was 37% of control. Longer periods of ventilation with 100% O2 resulted in DSPC falling to less than 40% of control. The injury was not reversed by reducing the O2 to 50%; rather, a progressive deterioration ensued. Acute respiratory failure (ARF) induced by 5 days of bacterial infection was very similar to that seen after 5 days of exposure to 100% O2. Ventilation with 80% O2 for 6 days resulted in smaller changes in DSPC but with differences in PG/PI comparable to those seen with 100% O2 or infection. We conclude that the ability of the type II cell to synthesize surfactant of normal composition is significantly impaired in these models of ARF. The earliest index of biochemical modification is the substantial change in PG/PI, which may be predictive of early lung injury. Further exacerbation of the injury could result in the reduction of DSPC content, with subsequent changes in lung mechanics and gas exchange.
King
R J
RJ
Department of Physiology, University of Texas Health Science Center, San Antonio.
Coalson
J J
JJ
Seidenfeld
J J
JJ
Anzueto
A R
AR
Smith
D B
DB
Peters
J I
JI
D000208:Acute Disease; D000818:Animals; D001992:Bronchoalveolar Lavage Fluid / Q000032:analysis*; D004195:Disease Models, Animal; D055370:Lung Injury; D008297:Male; D010100:Oxygen / Q000009:adverse effects; D010215:Papio; D011552:Pseudomonas Infections / Q000503:physiopathology*; D011663:Pulmonary Surfactants / Q000032:analysis*; D012128:Respiratory Distress Syndrome / Q000503:physiopathology; D012131:Respiratory Insufficiency / Q000503:physiopathology*; D012141:Respiratory Tract Infections / Q000382:microbiology / Q000503:physiopathology*
D011663:Pulmonary Surfactants; D010100:Oxygen